Aims This study aimed to investigate the impact of cardiac resynchronization therapy with a
defibrillator (CRT-D) on mortality, comparing it with CRT with a pacemaker (CRT-P) …

Aims The additional benefit of a defibrillator in cardiac resynchronization therapy (CRT)
patients is a matter of debate. Cause-of-death analysis in a CRT population has been …

Aims The choice of resynchronization therapy between with (CRT-D) and without (CRT-P) a
defibrillator remains a contentious issue. Cause-of-death analysis among CRT-P, compared …

Background Cardiac resynchronization therapy (CRT)-defibrillator (CRT-D) has been more
widely implanted than CRT-pacemaker (CRT-P) in patients of heart failure with reduced …

Background Cardiac resynchronization therapy (CRT) with or without a defibrillator has a
positive effect on mortality and morbidity for patients with heart failure. However …

BACKGROUND: Several clinical trials have confirmed that cardiac resynchronization
therapy (CRT) improves outcomes in well defined patient populations. It is uncertain …

Randomized clinical trials (RCTs) show that cardiac resynchronization therapy (CRT) can
reduce mortality and hospitalization rates in patients with heart failure due to left ventricular …

Background Current guidelines did not provide recommendations on indications of an
additional implantable cardioverter‐defibrillator (ICD) to patients receiving cardiac …

Aims Cardiac resynchronization therapy (CRT) is an established treatment for heart failure.
There is contradictory evidence whether defibrillator capability improves prognosis in …

Aims Cardiac resynchronization therapy (CRT) has been shown to improve symptoms and
exercise tolerance in patients with advanced heart failure (HF). However, studies were …